Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer
BRD4 has a pro-tumorigenic role but non-cell-autonomous mechanisms of BRD4 activation need to be elucidated. Here the authors unravel a mechanism by which CAFs activate BRD4 and induce resistance to BET inhibitors in cancer cells through IL6/IL8 signaling.
Guardado en:
Autores principales: | Wenyu Wang, Yen-An Tang, Qian Xiao, Wee Chyan Lee, Bing Cheng, Zhitong Niu, Gokce Oguz, Min Feng, Puay Leng Lee, Baojie Li, Zi-huan Yang, Yu-feng Chen, Ping Lan, Xiao-Jian Wu, Qiang Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a553e70c8d44ce0a3bbc3c4e74a210a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins
por: Francesca Malvezzi, et al.
Publicado: (2021) -
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Thomas C. Roberts, et al.
Publicado: (2017) -
A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells
por: Jovylyn Gatchalian, et al.
Publicado: (2018) -
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
por: Yi Bao, et al.
Publicado: (2020) -
Enhanced JunD/RSK3 signalling due to loss of BRD4/FOXD3/miR-548d-3p axis determines BET inhibition resistance
por: Fang Tai, et al.
Publicado: (2020)